Benefits and Safety of Early Tirofiban in the Treatment of Patients with Acute Coronary Syndrome : a Prospective , Multicenter and Randomized controlled trial.

Trial Profile

Benefits and Safety of Early Tirofiban in the Treatment of Patients with Acute Coronary Syndrome : a Prospective , Multicenter and Randomized controlled trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Tirofiban (Primary)
  • Indications Acute coronary syndromes; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms BESTOWAL
  • Most Recent Events

    • 22 Nov 2013 Planned number of patients changed from 3000 to 852 as reported by Chinese Clinical Trial Register.
    • 31 May 2013 Status changed from recruiting to completed as reported by Chinese Clinical Trial Register.
    • 21 May 2012 Planned end date changed from 1 May 2012 to 31 May 2013 as reported by Chinese Clinical Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top